Aris International Limited has provided additional regulatory disclosures regarding the resignation of Ms. Baljeet Kaur from her directorship position, following the company's December 15, 2025 board meeting announcement. The company submitted comprehensive documentation to BSE Limited on December 17, 2025, including the formal resignation letter and required regulatory annexures.

Formal Resignation Details

Ms. Baljeet Kaur submitted her formal resignation letter dated December 15, 2025, addressed to the Board of Directors. The resignation cited specific reasons related to corporate restructuring and takeover activities affecting the company's management structure.

In her resignation letter, Ms. Baljeet Kaur confirmed that apart from the management changes due to the takeover, there were no other material reasons for her departure. She expressed appreciation and gratitude to the management and Board members for their continuous support, cooperation, and trust during her tenure.

Regulatory Compliance Framework

The company's disclosure was made in compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, along with specific requirements under Para A(7C) of Part A of Schedule III. The submission also adhered to SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024.

Previous Board Changes

The resignation occurred simultaneously with the appointment of Mr. Dinesh Dhangare as Additional Executive Director on the same date. The Board Meeting was conducted on December 15, 2025, from 4:30 PM to 6:00 PM, where both the appointment and resignation were formally processed.

Company Information

Aris International Limited maintains its registered office at INS Tower, 7th Floor, Office No 707, A-wing, Bandra Kurla Complex, Bandra East, Mumbai-400051. The company's CIN number is L29130MH1995PLC249667, and stakeholders can reach the company at arisinternationalltd@gmail.com or visit www.arisinternational.in for further information.

Aris International Limited has announced a significant board meeting scheduled for August 1, 2025, to explore various fund-raising options. The company, headquartered in Mumbai, is set to discuss and potentially approve a range of capital-raising methods to support its future endeavors.

Key Highlights

• Board Meeting Date: August 1, 2025
• Purpose: To consider and approve fund-raising initiatives
• Potential Methods:
  • Public issues
  • Rights issues
  • ADRs/GDRs/FCCBs
  • Debt issues
  • Preferential allotment
  • Private placement
  • Qualified institutional placement (QIP)

Fund Raising Considerations

The board will deliberate on raising funds through various means, including the issuance of equity shares, convertible securities, or other eligible securities. Aris International is exploring multiple avenues to secure the necessary capital, demonstrating a flexible approach to meet its financial objectives.

Regulatory Compliance

The company has emphasized that any fund-raising initiative will be subject to shareholder approval and compliance with applicable regulatory requirements. This approach ensures transparency and adherence to corporate governance standards.

Trading Window Closure

In line with the Securities and Exchange Board of India (SEBI) regulations on insider trading, Aris International has closed its trading window with immediate effect. The window will remain closed until 48 hours after the conclusion of the board meeting, safeguarding against potential insider trading activities.

Company Background

Aris International Limited, with its Corporate Identification Number (CIN) L29130MH1995PLC249667, operates from its office at WeWork, Enam Sambhav, in the Bandra-Kurla Complex, Mumbai.

This strategic move by Aris International to explore diverse funding options could potentially impact its future growth trajectory and financial position. Investors and stakeholders will be keenly watching the outcomes of this crucial board meeting for insights into the company's expansion plans and capital strategy.